New EU Cosmetics Regulation
December 7, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The European Cosmetics Directive has been recast and the new legislation takes the form of Regulation 1223/2009. As a Regulation, …
Lonza to make Elan’s Alzheimer’s candidate
December 7, 2011Manufacturing and Production Abbott, Elan, Lonza
Elan has awarded a manufacturing contract to Lonza to supply the active pharmaceutical ingredient (API) for its small-molecule candidate Alzheimer’s …
Contract research news in brief
December 7, 2011Manufacturing and Production Almac, GVK Biosciences and PreClinOmics/AIT, PPD, Quintiles
Our round-up of news from the contract research sector includes PPD’s sales to a private equity consortium, new clinical supply …
Catalent Announces plans to increase Biologic Development and Manufacturing Capabilities
December 7, 2011Manufacturing and Production
SOMERSET, NJ, December 7, 2011 — Catalent Pharma Solutions, a leading provider of drug and biologic development services, delivery technologies …
Ketchum Pleon appoints Andrew Lamb as healthcare digital strategist
December 7, 2011Business Services, Medical Communications, Sales and Marketing Ketchum Pleon
Ketchum Pleon’s London office has appointed Andrew Lamb as a digital strategist for healthcare. Lamb will use his digital expertise …
Health Protection Agency welcomes the Approval of ERWINAZE™ Biologics License Application for Treatment of Acute Lymphoblastic Leukemia
December 7, 2011Manufacturing and Production
Salisbury, UK – 18th November 2011 –the Health Protection Agency (HPA) today welcomed the news that the U.S. Food and …
Roche unveils Zurich translational partnership
December 7, 2011Research and Development Roche, Zurich, academic alliance, translational research
Roche has unveiled a new research collaboration with academic researchers and leading clinical centres in Switzerland. The Basel-based pharma company …
NICE gains wider public health role
December 7, 2011Sales and Marketing NICE
NICE is to gain new powers to advise local authorities in England and Wales about public health.From 2013 responsibility for public health will …
No cancer link with Lantus, says Sanofi
December 7, 2011Sales and Marketing Cancer, Lantus, Sanofi, diabetes, insulin, safety
Sanofi has presented a new meta-analysis which suggests its insulin blockbuster Lantus does not raise the risk of cancer. A …
NICE recommends two Novartis cancer treatments
December 6, 2011Sales and Marketing Glivec, Novartis, Sprycel, Tasigna
Two of Novartis’ cancer drugs have been recommended by NICE for the first line treatment of chronic myeloid leukaemia (CML) …
GlaxoSmithKline moves closer to green power goals
December 6, 2011Manufacturing and Production GSK, manufacturing
GlaxoSmithKline took a step closer to becoming a generator of electricity in a bid to offset the high energy demands …
Pharma manufacturing news in brief
December 6, 2011Manufacturing and Production GSK, Hospira, PharmaS, UPS, Uquifa, Vivimed
India’s Vivimed buys Spanish API maker, Hospira tries to spend its way out of manufacturing woes, plus updates from PharmaS, …
SciGen sells Israeli vaccines plant to FDS
December 6, 2011Manufacturing and Production FDS, SciGen
UK drugmaker FDS Pharma has bought a manufacturing facility in Israel operated by Singapore biopharmaceutical concern SciGen. FDS Pharma has …
Actavis buys packager to boost manufacturing efficiencies
December 6, 2011Manufacturing and Production Actavis, pharmapack
Generic drugmaker Actavis has acquired Netherlands-based company PharmaPack International in a bid to cut its lead times for packaging and …
Cervarix was the ‘wrong decision’ for the UK
December 6, 2011Sales and Marketing
The UK government’s choice to use GlaxoSmithKline’s Cervarix for its HPV vaccination programme was the ‘wrong decision’, according to a …
Big pharma: big rewards come from big risks
December 5, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, R&D productivity
John LaMattina joined Pfizer in 1977 after having completed his PhD in organic chemistry, and moved up through the ranks …
AstraZeneca to freely share drug compounds with UK groups
December 5, 2011Research and Development, Sales and Marketing AstraZeneca, research
AstraZeneca will make 22 of its compounds available free of charge to UK academia next year as part of a …
Actelion Pharmaceuticals Takes to the Cloud with Global Deployment of Veeva CRM and iRep
December 5, 2011BARCELONA, Spain – 1 December, 2011 – Before selecting cloud-based Veeva CRM for 500+ users worldwide, Actelion Ltd. had been …
Roche’s Lung cancer test approved for Europe
December 5, 2011Research and Development, Sales and Marketing Roche, Tarceva, lung cancer
A new test which should help to better target treatment of patients with non-small cell lung cancer (NSCLC) has received …
Astellas adds two senior executives at US site
December 5, 2011Business Services, Manufacturing and Production, Sales and Marketing Astellas
Astellas’ US subsidiary Agensys has appointed Frank Hudson as vice president of finance, and Wolfgang Noe as vice president of …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
